USA News Group News Commentary – Stanford researchers achieved complete diabetes reversal in mice using a combined blood stem cell and ...

US health technology assessor the Institute for Clinical and Economic Review (ICER) today released a Final Evidence Report ...

LLY's explosive GLP-1 growth, deep obesity pipeline and strong estimate momentum give it the edge over MRK despite a richer valuation.

U.S. lawsuits against Novo Nordisk and Eli Lilly alleging patients taking weight loss drugs lost some or all of their ...

Novo Nordisk can end the horror year of 2025 on a positive note. The EMA has issued a positive opinion on a higher Wegovy ...

Today, Form Health, the national leader in science-based obesity and cardiometabolic care, announced access to new programs ...

Johnson & Johnson, which did not apply for the national priority voucher, was granted the ticket based on results from a ...

The Indian judiciary did well not to let Novo Nordisk extend its exclusive right to sell semaglutide, marketed as Ozempic and ...

Health care stocks have been on a run lately, leading the S&P 500’s 11 sectors over the past three months with a gain of ...

There is no exact known number of GLP-1 patients who say their say their sense of taste has changed since starting the ...

Becton Dickinson and Co, iShares U.S. Pharmaceuticals ETF, BlackRock Health Sciences Trust. Read 's Market Analysis on Investing.com ...